AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 6 - (NewsRx.com & NewsRx.net) -- Hormone replacement therapy after melanoma does not adversely affect prognosis.
"A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis," wrote researchers in Scotland.
"In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma," R.M. Mackie and colleagues reported.
"After controlling for known prognostic factors," investigators concluded "that HRT after melanoma does not adversely affect prognosis."
Mackie and colleagues published their study in British Journal of ...
Source: HighBeam Research, Hormone replacement therapy after melanoma does not adversely affect...